GENE-MAVNCT04772963
Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV)
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved at least 10 months later.
See at-risk trials from Fondation Ophtalmologique Adolphe de Rothschild
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 11 versions: 10 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Mar 2026 to Feb 2027
- Eligibility criteria expanded, about 2 words
- Minor Study completion date: Oct 2026 to Mar 2027v10
- Notable Primary completion date: Oct 2024 to Mar 2026v9
- Minor Study description expanded, about 239 wordsv8
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Feb 2022 to Feb 17, 2022
Show 4 earlier versionsHide 4 earlier versions
- Notable Start date: Oct 2021 to Feb 2022v5
- Notable Start date: Aug 2021 to Oct 2021
- Primary completion date: Aug 2024 to Oct 2024
- Study completion date: Aug 2026 to Oct 2026
- Notable Start date: Apr 2021 to Aug 2021
- Primary completion date: Apr 2024 to Aug 2024
- Study completion date: Apr 2026 to Aug 2026
- Minor Study title shortened, about 12 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Genetic mutation
Timeframe: limit of 12 month
Arms and interventions
Genetic: blood sample
Sites
1 site in 1 country
- HOPITAL FONDATION Adolphe de ROTHSCHILDParis, France